Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine

By Serezani C.H.C.   Franco A.R.   Wajc M.   Umada Yokoyama-Yasunaka J.K.   Wunderlich G.   Borges M.M.   Uliana S.R.B.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3755-3763

Elsevier

Access to resources Recommend Favorite

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults

By Leroux-Roels G.   Desombere I.   De Tollenaere G.   Petit M.-A.   Desmons P.   Hauser P.   Delem A.   De Grave D.   Safary A.  

Vaccine, Vol. 15, Iss. 16, 1997-11 ,pp. : 1724-1731

Elsevier

Access to resources Recommend Favorite

Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate

By Wang S.   Liu X.   Fisher K.   Smith J.G.   Chen F.   Tobery T.W.   Ulmer J.B.   Evans R.K.   Caulfield M.J.  

Vaccine, Vol. 18, Iss. 13, 2000-01 ,pp. : 1227-1235

Elsevier

Access to resources Recommend Favorite

DNA-mediated immunization to hepatitis B surface antigen: longevity of primary response and effect of boost

By Davis H.L.   Mancini M.   Michel M.-L.   Whalen R.G.  

Vaccine, Vol. 14, Iss. 9, 1996-06 ,pp. : 910-915

Elsevier

Access to resources Recommend Favorite

Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres

By Dentico P.   Crovari P.   Lai P.L.   Ponzio F.   Safary A.   Pellegrino A.   Meurice F.   Di Pasquale A.   Tornieporth N.   Volpe A.   Icardi G.  

Vaccine, Vol. 20, Iss. 31, 2002-11 ,pp. : 3725-3730

Elsevier

Access to resources Recommend Favorite